caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1891819512

Robert GarvinMD

PRACTICEGEISINGER CLINCSee all providers at this practice →
Vascular SurgeryDanville, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Robert Garvin's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 105 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
GEISINGER MEDICAL CENTER7543,024
James Elmore
Vascular Surgery · Danville, PA
157390
John Gray
Vascular Surgery · Danville, PA
144386
Matthew Cindric
Vascular Surgery · Scranton, PA
129309
William Haynos
Cardiology · Danville, PA
4882
GEISINGER MEDICAL CENTER4597
GEISINGER MEDICAL CENTER44114
Thomas Harrison
Cardiology · Danville, PA
4186
Randle Storm
Clinical Cardiac Electrophysiology · Danville, PA
4061
Clayton Jones
Clinical Cardiac Electrophysiology · Concord, NH
3972
MAHMUD, FARUQ3971
EVANGELICAL COMMUNITY HOSPITAL35141
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,003
Unique beneficiaries
—
Total services
1,137
Distinct HCPCS
16
Medicare payment
$53K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 197 Vascular Surgery providers in PA — top quintile (cohort median 848).
PRESCRIBING · PART D · 2024
Total Rx claims
21
Beneficiaries
—
Total drug cost
$11K
Distinct drugs
1
Brand share
100.0%
Top prescribed drugs
Evolocumab21 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$131
Payment records
4
By payment type
Food and Beverage$131